Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer. [electronic resource]
Producer: 19970904Description: 363-70 p. digitalISSN:- 0030-2414
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Small Cell -- drug therapy
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Feasibility Studies
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematopoiesis -- drug effects
- Humans
- Ifosfamide -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Recombinant Proteins
- Thrombocytopenia -- chemically induced
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.